Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms.
Ravandi F, Aribi A, O'Brien S, Faderl S, Jones D, Ferrajoli A, Huang X, York S, Pierce S, Wierda W, Kontoyiannis D, Verstovsek S, Pro B, Fayad L, Keating M, Kantarjian H. Ravandi F, et al. Among authors: york s. J Clin Oncol. 2009 Nov 10;27(32):5425-30. doi: 10.1200/JCO.2009.22.6688. Epub 2009 Oct 5. J Clin Oncol. 2009. PMID: 19805674 Free PMC article. Clinical Trial.
Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia.
Ravandi F, O'Brien S, Jorgensen J, Pierce S, Faderl S, Ferrajoli A, Koller C, Challagundla P, York S, Brandt M, Luthra R, Burger J, Thomas D, Keating M, Kantarjian H. Ravandi F, et al. Among authors: york s. Blood. 2011 Oct 6;118(14):3818-23. doi: 10.1182/blood-2011-04-351502. Epub 2011 Aug 5. Blood. 2011. PMID: 21821712 Free PMC article. Clinical Trial.
Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study.
Kantarjian H, Thomas D, Jorgensen J, Jabbour E, Kebriaei P, Rytting M, York S, Ravandi F, Kwari M, Faderl S, Rios MB, Cortes J, Fayad L, Tarnai R, Wang SA, Champlin R, Advani A, O'Brien S. Kantarjian H, et al. Among authors: york s. Lancet Oncol. 2012 Apr;13(4):403-11. doi: 10.1016/S1470-2045(11)70386-2. Epub 2012 Feb 21. Lancet Oncol. 2012. PMID: 22357140 Clinical Trial.
Phase 1/2 trial of XPO1 inhibitor selinexor plus docetaxel in previously treated, advanced KRAS mutant non-small cell lung cancer.
von Itzstein MS, Burns TF, Dowell JE, Horn L, Camidge DR, York SJ, Eaton KD, Kyle K, Fattah FJ, Liu J, Mu-Mosley H, Gupta A, Nadeem U, Gao A, Zhang S, Gerber DE. von Itzstein MS, et al. Among authors: york sj. Clin Cancer Res. 2024 Dec 9. doi: 10.1158/1078-0432.CCR-24-1722. Online ahead of print. Clin Cancer Res. 2024. PMID: 39651955
Study protocol for the Multimodal Approach to Preventing Suicide in Schools (MAPSS) project: A regionally based feasibility trial of an integrated response to suicide risk among UK secondary school pupils.
Ashworth E, McCarthy M, Wynne S, Robinson J, McKay S, Lane S, Richardson G, Boardman N, Henderson K, Crosbie V, Humphrey N, York S, Michail M, Hart D, Clacy D, Jalota M, Saini P. Ashworth E, et al. Among authors: york s. PLoS One. 2024 Jul 26;19(7):e0302873. doi: 10.1371/journal.pone.0302873. eCollection 2024. PLoS One. 2024. PMID: 39058694 Free PMC article.
Duration of Induction of Labor for Second-Trimester Medication Abortion and Adverse Outcomes.
Premkumar A, Manthena V, Wascher J, Wanyonyi EK, Johnson C, Vuppaladhadiam L, Chor J, Plunkett BA, Ryan I, Mbah O, Lee J, Barker E, Laursen L, McCloskey LR, York SL. Premkumar A, et al. Among authors: york sl. Obstet Gynecol. 2024 Sep 1;144(3):367-376. doi: 10.1097/AOG.0000000000005663. Epub 2024 Jul 11. Obstet Gynecol. 2024. PMID: 38991214
Conserved long noncoding RNA TILAM promotes liver fibrosis through interaction with PML in HSCs.
Sun C, Zhou C, Daneshvar K, Ben Saad A, Kratkiewicz AJ, Toles BJ, Arghiani N, Hess A, Chen JY, Pondick JV, York SR, Li W, Moran SP, Gentile SD, Rahman RU, Li Z, Zhou P, Sparks RP, Habboub T, Kim BM, Choi MY, Affo S, Schwabe RF, Popov YV, Mullen AC. Sun C, et al. Among authors: york sr. Hepatology. 2024 Apr 2. doi: 10.1097/HEP.0000000000000822. Online ahead of print. Hepatology. 2024. PMID: 38563629
229 results